Findings

What do systematic reviews say?

4,919 questions · 13,869 findings · 2,177 reviews · Headline outcomes only

Sort:Best matchNewestHighest certainty Download CSV

No studies found 13,869 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Erythromycin plus nasogastric tube lavage vs metoclopramide plus nasogastric tube lavage

UGIH‐related mortality · people with acute UGIH

The review found no eligible studies for this question.

1 finding from 1 review

Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Erythromycin plus nasogastric tube lavage vs metoclopramide plus nasogastric tube lavage

All‐cause mortality · people with acute UGIH

The review found no eligible studies for this question.

1 finding from 1 review

Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Erythromycin plus nasogastric tube lavage vs metoclopramide plus nasogastric tube lavage

Rebleeding · people with acute UGIH

The review found no eligible studies for this question.

1 finding from 1 review

Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Meglitinides vs sulphonylureas

Adverse events other than hypoglycaemia

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Meglitinides vs sulphonylureas

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Meglitinides vs sulphonylureas

Treatment satisfaction

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SGLT‐2 inhibitors vs sulphonylureas

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SGLT‐2 inhibitors vs sulphonylureas

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SGLT‐2 inhibitors vs sulphonylureas

Treatment satisfaction

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

DPP‐4 inhibitors vs sulphonylureas

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

GLP‐1 analogues inhibitors vs sulphonylureas

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

GLP‐1 analogues inhibitors vs sulphonylureas

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Insulin analogues vs biphasic insulin

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Insulin analogues vs biphasic insulin

Treatment satisfaction

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Telemedicine vs usual care

Adverse events other than hypoglycaemia

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Telemedicine vs usual care

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Telemedicine vs usual care

Treatment satisfaction

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Patient education vs usual care

Health‐related quality of life

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Patient education vs usual care

Adverse events other than hypoglycaemia

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Patient education vs usual care

All‐cause mortality

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found